AbbVie Inc. Contracts & Agreements

132 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Underwriting Agreement, dated February 22, 2024, by and among AbbVie Inc., Morgan Stanley & Co. LLC, J.P. Morgan Securities LLC, BofA Securities, Inc. and Citigroup Global Markets...
Underwriting Agreements
AbbVie Inc.
2024
Supplemental Indenture No. 10, dated February 26, 2024, between AbbVie Inc. and U.S. Bank Trust Company, National Association, as trustee
Indenture Agreements
AbbVie Inc.
2024
Form of 4.800% Note due 2027 (included in Exhibit 4.2 of this Current Report on Form 8-K)
Note Agreements
AbbVie Inc.
2024
Form of 4.800 Note due 2029 (included in Exhibit 4.2 of this Current Report on Form 8-K)
Note Agreements
AbbVie Inc.
2024
Form of 4.950% Note due 2031 (included in Exhibit 4.2 of this Current Report on Form 8-K)
Note Agreements
AbbVie Inc.
2024
Form of 5.050% Note due 2034 (included in Exhibit 4.2 of this Current Report on Form 8-K)
Note Agreements
AbbVie Inc.
2024
Form of 5.350% Note due 2044 (included in Exhibit 4.2 of this Current Report on Form 8-K)
Note Agreements
AbbVie Inc.
2024
Form of 5.400% Note due 2054 (included in Exhibit 4.2 of this Current Report on Form 8-K)
Note Agreements
AbbVie Inc.
2024
Form of 5.500% Note due 2064 (included in Exhibit 4.2 of this Current Report on Form 8-K)
Note Agreements
AbbVie Inc.
2024
Description of the companys securities registered pursuant to Section 12 of the Securities Exchange Act of 1934
AbbVie Inc.
2024
Second Amended and Restated Revolving Credit Agreement, dated as of March 28, 2023, among AbbVie, the lenders and other parties party thereto and JPMorgan Chase Bank, N.A., as...
Credit Agreements
AbbVie Inc.
Biotechnology
DE
2023
Form of Agreement Regarding Change in Control by and between AbbVie Inc. and its named executive officers
Change of Control Agreements
AbbVie Inc.
2022
AbbVie Non-Employee Directors Fee Plan, as amended and restated
AbbVie Inc.
Biotechnology
2022
Form of AbbVie Inc. Performance-Vested Restricted Stock Unit Agreement
Stock Agreements
AbbVie Inc.
Biotechnology
IL
2022
Form of AbbVie Inc. Performance Share Award Agreement
Bonus & Incentive Agreements
AbbVie Inc.
Biotechnology
IL
2022
Form of AbbVie Inc. Non-Employee Director RSU Agreement (US)
AbbVie Inc.
Biotechnology
IL
2022
Form of AbbVie Inc. Non-Qualified Stock Option Agreement
Stock Agreements
AbbVie Inc.
2022
Form of AbbVie Inc. Retention RSU Agreement Ratable Vesting
Retention Agreements
AbbVie Inc.
Biotechnology
IL
2022
Form of AbbVie Inc. Retention RSU Agreement Cliff Vesting with Dividend Equivalent Accrual
Retention Agreements
AbbVie Inc.
Biotechnology
IL
2022
Description of the companys securities registered pursuant to Section 12 of the Securities Exchange Act of 1934
AbbVie Inc.
Biotechnology
NY
2022
AbbVie Performance Incentive Plan, as amended and restated
Bonus & Incentive Agreements
AbbVie Inc.
2022
AbbVie Supplemental Pension Plan, as amended and restated
AbbVie Inc.
Biotechnology
2022
AbbVie Supplemental Savings Plan, as amended and restated
AbbVie Inc.
2022
Description of the companys securities registered pursuant to Section 12 of the Securities Exchange Act of 1934
AbbVie Inc.
Biotechnology
NY
2021
Form of AbbVie Inc. Performance-Vested Restricted Stock Unit Agreement
Stock Agreements
AbbVie Inc.
2021
Form of AbbVie Inc. Performance Share Award Agreement
Bonus & Incentive Agreements
AbbVie Inc.
2021
Form of AbbVie Inc. Non-Employee Director RSU Agreement (US)
AbbVie Inc.
Biotechnology
IL
2021
Form of AbbVie Inc. Non-Qualified Stock Option Agreement
Stock Agreements
AbbVie Inc.
Biotechnology
IL
2021
Form of AbbVie Inc. Retention RSU Agreement - Ratable Vesting
Retention Agreements
AbbVie Inc.
2021
Description of the companys securities registered pursuant to Section 12 of the Securities Exchange Act of 1934
AbbVie Inc.
2021
Supplemental Indenture No. 8, dated May 14, 2020, by and between AbbVie Inc. and U.S. Bank National Association, as trustee
Indenture Agreements
AbbVie Inc.
2020
Supplemental Indenture No. 9, dated May 14, 2020, among AbbVie Inc., U.S. Bank National Association, as trustee, transfer agent and registrar, and Elavon Financial Services DAC,...
Indenture Agreements
AbbVie Inc.
2020
Agency Agreement, dated May 14, 2020, among AbbVie Inc., U.S. Bank National Association, as trustee, transfer agent and registrar, and Elavon Financial Services DAC, U.K. Branch,...
Agency Agreements
AbbVie Inc.
Biotechnology
IL
2020
Registration Rights Agreement, dated May 14, 2020, among AbbVie Inc. and Morgan Stanley & Co. LLC, BofA Securities, Inc., Citigroup Global Markets Inc., BNP Paribas Securities...
Registration Rights Agreements
AbbVie Inc.
Biotechnology
NY
2020
Amendment to the Transaction Agreement, dated as of May 5, 2020, between AbbVie Inc., Allergan plc and Venice Subsidiary, LLC
AbbVie Inc.
Biotechnology
DE
2020
Form of AbbVie Inc. Performance-Vested Restricted Stock Unit Agreement
Stock Agreements
AbbVie Inc.
2020
Form of AbbVie Inc. Performance Share Award Agreement
Bonus & Incentive Agreements
AbbVie Inc.
2020
Form of AbbVie Inc. Non-Employee Director RSU Agreement (US)
AbbVie Inc.
2020
Form of AbbVie Inc. Non-Qualified Stock Option Agreement
Stock Agreements
AbbVie Inc.
Biotechnology
IL
2020
Form of AbbVie Inc. Retention RSU Agreement - Ratable Vesting
Retention Agreements
AbbVie Inc.
2020
AbbVie Non-Employee Directors' Fee Plan, as amended and restated
AbbVie Inc.
2020
Description of the companys securities registered pursuant to Section 12 of the Securities Exchange Act of 1934
AbbVie Inc.
2020
Purchase Agreement, dated November 12, 2019, among AbbVie Inc. and Morgan Stanley & Co. LLC, BofA Securities, Inc. and Barclays Capital Inc. (acting for themselves and as...
Purchase Agreements
AbbVie Inc.
2019
AbbVie Non-Employee Directors' Fee Plan, as amended and restated
AbbVie Inc.
Biotechnology
2019
Supplemental Indenture No. 6, dated September 26, 2019, among AbbVie Inc., U.S. Bank National Association, as trustee, transfer agent and registrar, and Elavon Financial Services...
Indenture Agreements
AbbVie Inc.
Biotechnology
NY
2019
Agency Agreement, dated September 26, 2019, among AbbVie Inc., U.S. Bank National Association, as trustee, transfer agent and registrar, and Elavon Financial Services DAC, UK...
Agency Agreements
AbbVie Inc.
Biotechnology
NY
2019
Underwriting Agreement, dated September 17, 2019, among AbbVie Inc. and Morgan Stanley & Co. International plc, HSBC Bank plc and Merrill Lynch International (acting for...
Underwriting Agreements
AbbVie Inc.
Biotechnology
IL
2019
Amended and Restated Revolving Credit Agreement, dated as of August 27, 2019, among AbbVie, the lenders and other parties party thereto and JPMorgan Chase Bank, N.A., as...
Credit Agreements
AbbVie Inc.
2019
AbbVie Supplemental Pension Plan, as amended and restated
AbbVie Inc.
2019
AbbVie 2013 Incentive Stock Program Second Amendment
Bonus & Incentive Agreements
AbbVie Inc.
2019
364-Day Term Loan Credit Agreement, dated as of July 12, 2019, among AbbVie, certain lenders party thereto and Morgan Stanley Senior Funding, Inc., as administrative agent
Loan Agreements
AbbVie Inc.
Biotechnology
DE
2019
First Amendment to Revolving Credit Agreement, dated as of July 12, 2019, among AbbVie, the lenders and other parties party thereto and JPMorgan Chase Bank, N.A., as...
Credit Agreements
AbbVie Inc.
Biotechnology
NY
2019
Appendix III to the Rule 2.5 Announcement, dated as of June 25, 2019 (Conditions Appendix)
AbbVie Inc.
2019
Expenses Reimbursement Agreement, dated as of June 25, 2019, between AbbVie and Allergan
AbbVie Inc.
Biotechnology
DE
2019
Transaction Agreement, dated as of June 25, 2019, between AbbVie, Allergan and Acquirer Sub
AbbVie Inc.
Biotechnology
NY
2019
364-Day Bridge Credit Agreement, dated as of June 25, 2019, among AbbVie, Morgan Stanley Senior Funding, Inc. and the lenders party thereto
Credit Agreements
AbbVie Inc.
Biotechnology
DE
2019
Form of AbbVie Inc. Performance-Vested Restricted Stock Unit Agreement
Stock Agreements
AbbVie Inc.
Biotechnology
DE
2019
Form of AbbVie Inc. Performance Share Award Agreement
Bonus & Incentive Agreements
AbbVie Inc.
2019
Form of AbbVie Inc. Non-Employee Director RSU Agreement (US)
AbbVie Inc.
2019
Form of AbbVie Inc. Non-Qualified Stock Option Agreement
Stock Agreements
AbbVie Inc.
Biotechnology
DE
2019
Form of AbbVie Inc. Non-Employee Director Non-Qualified Stock Option Agreement
Stock Agreements
AbbVie Inc.
2019
Underwriting Agreement, dated September 13, 2018, by and among AbbVie Inc., Merrill Lynch, Pierce, Fenner & Smith Incorporated, J.P. Morgan Securities LLC, Morgan Stanley & Co....
Underwriting Agreements
AbbVie Inc.
2018
Supplemental Indenture No. 5, dated September 18, 2018, between AbbVie Inc. and U.S. Bank National Association, as trustee
Indenture Agreements
AbbVie Inc.
2018
Revolving Credit Agreement, dated as of August 31, 2018, among AbbVie, the lenders and other parties party thereto, and JPMorgan Chase Bank, N.A., as administrative agent
Credit Agreements
AbbVie Inc.
Biotechnology
NY
2018
First Amendment to 364-Day Term Loan Credit Agreement, dated as of August 31, 2018, among AbbVie, the lenders and other parties party thereto, and Bank of America, N.A., as...
Loan Agreements
AbbVie Inc.
Biotechnology
NY
2018
364-Day Term Loan Credit Agreement, dated as of May 17, 2018, among AbbVie, the lenders and other parties party thereto, and Bank of America, N.A., as administrative agent
Loan Agreements
AbbVie Inc.
2018
Form of AbbVie Inc. Performance-Vested Restricted Stock Unit Agreement
Stock Agreements
AbbVie Inc.
2018
Form of AbbVie Inc. Performance Share Award Agreement
Bonus & Incentive Agreements
AbbVie Inc.
2018
Form of AbbVie Inc. Non-Employee Director RSU Agreement (US)
AbbVie Inc.
Biotechnology
DE
2018
Form of AbbVie Inc. Non-Qualified Stock Option Agreement
Stock Agreements
AbbVie Inc.
2018
Form of AbbVie Inc. Non-Employee Director Non-Qualified Stock Option Agreement
Stock Agreements
AbbVie Inc.
2018
Form of AbbVie Inc. Performance Share Award Agreement
Bonus & Incentive Agreements
AbbVie Inc.
2018
AbbVie Non-Employee Directors' Fee Plan, as amended and restated
AbbVie Inc.
Biotechnology
2018
ABBVIE INC. NON-EMPLOYEE DIRECTOR RESTRICTED STOCK UNIT AGREEMENT
Stock Agreements
AbbVie Inc.
2017
ABBVIE INC. NON-QUALIFIED STOCK OPTION AGREEMENT
Stock Agreements
AbbVie Inc.
2017
ABBVIE INC. PERFORMANCE SHARE AWARD AGREEMENT
Bonus & Incentive Agreements
AbbVie Inc.
Biotechnology
DE
2017
ABBVIE INC. PERFORMANCE-VESTED RESTRICTED STOCK UNIT AGREEMENT
Stock Agreements
AbbVie Inc.
Biotechnology
DE
2017
ABBVIE DEFERRED COMPENSATION PLAN (Amended and Restated Effective as of January 1, 2017) ABBVIE DEFERRED COMPENSATION PLAN ARTICLE I INTRODUCTION
Compensation Agreements
AbbVie Inc.
Biotechnology
IL
2017
ABBVIE SUPPLEMENTAL PENSION PLAN (Amended and Restated Effective as of January 1, 2016) ABBVIE SUPPLEMENTAL PENSION PLAN SECTION 1 INTRODUCTION
AbbVie Inc.
Biotechnology
2017
ABBVIE INC. 1,400,000,000 0.375% Senior Notes due 2019 1,450,000,000 1.375% Senior Notes due 2024 750,000,000 2.125% Senior Notes due 2028 UNDERWRITING AGREEMENT
Underwriting Agreements
AbbVie Inc.
2016
ABBVIE INC. SUPPLEMENTAL INDENTURE NO. 4 1,400,000,000 0.375% Senior Notes due 2019 1,450,000,000 1.375% Senior Notes due 2024 750,000,000 2.125% Senior Notes due 2028
Indenture Agreements
AbbVie Inc.
Biotechnology
NY
2016
DATED NOVEMBER 17, 2016 ISSUER PAYING AGENT TRANSFER AGENT REGISTRAR - AND - TRUSTEE AGENCY AGREEMENT relating to Notes issued under a prospectus dated April 27, 2015, as...
Note Agreements
AbbVie Inc.
Biotechnology
IL
2016
AMENDMENT NO. 1 TO AGREEMENT AND PLAN OF MERGER
Merger Agreements
AbbVie Inc.
2016
ABBVIE INC. $1,800,000,000 2.300% Senior Notes due 2021 $1,000,000,000 2.850% Senior Notes due 2023 $2,000,000,000 3.200% Senior Notes due 2026 $1,000,000,000 4.300% Senior Notes...
Underwriting Agreements
AbbVie Inc.
2016
ABBVIE INC. SUPPLEMENTAL INDENTURE NO. 3 $1,800,000,000 2.300% Senior Notes due 2021 $1,000,000,000 2.850% Senior Notes due 2023 $2,000,000,000 3.200% Senior Notes due 2026...
Indenture Agreements
AbbVie Inc.
Biotechnology
NY
2016
ABBVIE INC. NON-EMPLOYEE DIRECTOR RESTRICTED STOCK UNIT AGREEMENT
Stock Agreements
AbbVie Inc.
2016
ABBVIE INC. NON-QUALIFIED STOCK OPTION AGREEMENT
Stock Agreements
AbbVie Inc.
Biotechnology
DE
2016
ABBVIE INC. RESTRICTED STOCK UNIT AGREEMENT
Stock Agreements
AbbVie Inc.
Biotechnology
DE
2016
ABBVIE INC. RESTRICTED STOCK UNIT AGREEMENT
Stock Agreements
AbbVie Inc.
2016
ABBVIE INC. RESTRICTED STOCK AGREEMENT
Stock Agreements
AbbVie Inc.
2016
ABBVIE INC. RESTRICTED STOCK AGREEMENT
Stock Agreements
AbbVie Inc.
2016
ABBVIE INC. PERFORMANCE SHARE AWARD AGREEMENT
Bonus & Incentive Agreements
AbbVie Inc.
Biotechnology
DE
2016
ABBVIE INC. PERFORMANCE-VESTED RESTRICTED STOCK UNIT AGREEMENT
Stock Agreements
AbbVie Inc.
Biotechnology
DE
2016
AGREEMENT AND PLAN OF MERGER Dated as of April 25, 2016 by and among STEMCENTRX, INC., ABBVIE INC., SIRIUS SONOMA CORPORATION, SIRIUS SONOMA LLC and, solely for the purposes set...
Merger Agreements
AbbVie Inc.
2016
ABBVIE PERFORMANCE INCENTIVE PLAN (Amended and Restated Effective as of January 1, 2015)
Bonus & Incentive Agreements
AbbVie Inc.
Biotechnology
2016
ABBVIE DEFERRED COMPENSATION PLAN (Amended and Restated Effective as of January 1, 2015)
Compensation Agreements
AbbVie Inc.
Biotechnology
IL
2016
ABBVIE NON-EMPLOYEE DIRECTORS FEE PLAN (Amended and Restated Effective as of May 6, 2016)
AbbVie Inc.
Biotechnology
2016
ABBVIE SUPPLEMENTAL SAVINGS PLAN (Amended and Restated Effective as of January 1, 2015)
AbbVie Inc.
2016
$2,000,000,000 THREE-YEAR TERM LOAN CREDIT AGREEMENT Dated as of September 25, 2015 among ABBVIE INC., as Borrower, VARIOUS FINANCIAL INSTITUTIONS, as Lenders, and BANK OF...
Loan Agreements
AbbVie Inc.
Biotechnology
DE
2015
$2,000,000,000 364-DAY TERM LOAN CREDIT AGREEMENT Dated as of September 25, 2015 among ABBVIE INC., as Borrower, VARIOUS FINANCIAL INSTITUTIONS, as Lenders, and BANK OF AMERICA,...
Loan Agreements
AbbVie Inc.
Biotechnology
DE
2015
ABBVIE INC. SUPPLEMENTAL INDENTURE NO. 2 $3,000,000,000 1.800% Senior Notes due 2018 $3,750,000,000 2.500% Senior Notes due 2020 $1,000,000,000 3.200% Senior Notes due 2022...
Indenture Agreements
AbbVie Inc.
Biotechnology
NY
2015
ABBVIE INC. $3,000,000,000 1.800% Notes due 2018 $3,750,000,000 2.500% Notes due 2020 $1,000,000,000 3.200% Notes due 2022 $3,750,000,000 3.600% Notes due 2025 $2,500,000,000...
Underwriting Agreements
AbbVie Inc.
2015
$18,000,000,000 364DAY BRIDGE TERM LOAN CREDIT AGREEMENT Dated as of March 27, 2015 among ABBVIE INC., as Borrower, VARIOUS FINANCIAL INSTITUTIONS, as Lenders, and MORGAN STANLEY...
Loan Agreements
AbbVie Inc.
2015
AMENDMENT NO. 1 TO AGREEMENT AND PLAN OF REORGANIZATION
Plan of Reorganization Agreements
AbbVie Inc.
Biotechnology
DE
2015
AMENDMENT NO. 1 TO REVOLVING CREDIT AGREEMENT
Credit Agreements
AbbVie Inc.
2015
AGREEMENT AND PLAN OF REORGANIZATION by and among ABBVIE INC., OXFORD AMHERST CORPORATION, OXFORD AMHERST LLC and PHARMACYCLICS, INC. dated as of March 4, 2015
Plan of Reorganization Agreements
AbbVie Inc.
Biotechnology
DE
2015
SUPPORT AGREEMENT
AbbVie Inc.
Biotechnology
DE
2015
20 October 2014 ABBVIE INC. and SHIRE PLC TERMINATION AGREEMENT Herbert Smith Freehills LLP 1
Termination Agreements
AbbVie Inc.
Biotechnology
DE
2014
3,200,000,000 TERM LOAN CREDIT AGREEMENT Dated as of August 18, 2014 among ABBVIE HOLDINGS PRIVATE LIMITED, as Borrower, the GUARANTORS party hereto, VARIOUS FINANCIAL...
Loan Agreements
AbbVie Inc.
Biotechnology
NY
2014
$4,000,000,000 REVOLVING CREDIT AGREEMENT Dated as of August 18, 2014 among ABBVIE INC. and ABBVIE PRIVATE LIMITED, as Borrowers, the GUARANTOR party hereto, VARIOUS FINANCIAL...
Credit Agreements
AbbVie Inc.
Biotechnology
NY
2014
AMENDMENT NO. 1 TO 364-DAY BRIDGE CREDIT AGREEMENT August 11, 2014
Credit Agreements
AbbVie Inc.
Biotechnology
NY
2014
RECOMMENDED COMBINATION OF SHIRE PLC AND ABBVIE INC.
AbbVie Inc.
2014
18 July 2014 ABBVIE INC and SHIRE PLC CO-OPERATION AGREEMENT Herbert Smith Freehills LLP 1
Cooperation Agreements
AbbVie Inc.
Biotechnology
DE
2014
13,500,000,000 364-DAY BRIDGE CREDIT AGREEMENT Dated as of July 17, 2014 among ABBVIE PRIVATE LIMITED, as Borrower, the GUARANTORS party hereto, VARIOUS FINANCIAL INSTITUTIONS, as...
Credit Agreements
AbbVie Inc.
Biotechnology
NY
2014
FIRST AMENDMENT TO INTERNATIONAL COMMERCIAL OPERATIONS AGREEMENT
AbbVie Inc.
Biotechnology
DE
2014
FIRST AMENDMENT TO LUXEMBOURG INTERNATIONAL COMMERCIAL OPERATIONS AGREEMENT
AbbVie Inc.
2014
ABBVIE INC. NON-EMPLOYEE DIRECTOR RESTRICTED STOCK UNIT AGREEMENT
Stock Agreements
AbbVie Inc.
2013
ABBVIE INC. NON-EMPLOYEE DIRECTOR NON-QUALIFIED STOCK OPTION AGREEMENT
Stock Agreements
AbbVie Inc.
2013
ABBVIE INC. PERFORMANCE RESTRICTED STOCK AGREEMENT
Bonus & Incentive Agreements
AbbVie Inc.
Biotechnology
DE
2013
ABBVIE INC. PERFORMANCE RESTRICTED STOCK AGREEMENT
Bonus & Incentive Agreements
AbbVie Inc.
2013
ABBVIE INC. PERFORMANCE RESTRICTED STOCK AGREEMENT
Bonus & Incentive Agreements
AbbVie Inc.
2013
ABBVIE INC. NON-QUALIFIED STOCK OPTION AGREEMENT
Stock Agreements
AbbVie Inc.
Biotechnology
DE
2013
ABBVIE INC. NON-QUALIFIED REPLACEMENT STOCK OPTION AGREEMENT
Stock Agreements
AbbVie Inc.
Biotechnology
DE
2013
ABBVIE 2013 MANAGEMENT INCENTIVE PLAN (Effective as of January 1, 2013 and conformed through the First Amendment)
Bonus & Incentive Agreements
AbbVie Inc.
2013
ABBVIE 2013 PERFORMANCE INCENTIVE PLAN (Effective as of January 1, 2013)
Bonus & Incentive Agreements
AbbVie Inc.
2013
ABBVIE DEFERRED COMPENSATION PLAN (Effective as of January 1, 2013)
Compensation Agreements
AbbVie Inc.
Biotechnology
IL
2013
ABBVIE NON-EMPLOYEE DIRECTORS FEE PLAN (Effective as of January 1, 2013)
AbbVie Inc.
2013
ABBVIE SUPPLEMENTAL PENSION PLAN (Effective as of January 1, 2013)
AbbVie Inc.
Biotechnology
2013
ABBVIE SUPPLEMENTAL SAVINGS PLAN (Effective as of January 1, 2013)
AbbVie Inc.
Biotechnology
2013
U.S. TRANSITION SERVICES AGREEMENT BY AND BETWEEN ABBOTT LABORATORIES AND ABBVIE INC. DATED AS OF DECEMBER 31, 2012
Transition Agreements
AbbVie Inc.
2013
EX-U.S. TRANSITION SERVICES AGREEMENT BY AND BETWEEN ABBOTT LABORATORIES AND ABBVIE INC. DATED AS OF DECEMBER 31, 2012
Transition Agreements
AbbVie Inc.
2013
TAX SHARING AGREEMENT Between ABBOTT LABORATORIES on behalf of itself and the ABBOTT AFFILIATES and ABBVIE INC. on behalf of itself and the ABBVIE AFFILIATES
AbbVie Inc.
2013